InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Davis Stephen, Chairman & CEO. Director active across 4 companies, notably Acadia Pharmaceuticals INC. Aggregated, 34 filings have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €4.4m. Activity tracked since 22 December 2021. The latest transaction was filed on 19 August 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Davis Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
31,747 shares@ US$15.287.0% of flowCommon StockSEC:0001415889-24-021724:2
17,333 shares0Common StockSEC:0001415889-24-021724:0
44,782 shares0Common StockSEC:0001415889-24-021724:1
22,391 sharesCommon StockSEC:0001415889-24-012238:0
8,858 shares@ US$17.872.3% of flowCommon StockSEC:0001415889-24-010604:2
17,716 shares@ US$17.874.7% of flowCommon StockSEC:0001415889-24-010604:3
34,666 sharesCommon StockSEC:0001415889-24-010604:1
17,333 sharesCommon StockSEC:0001415889-24-010604:0
34,666 shares0Common StockSEC:0001415889-24-009271:0
10,946 sharesCommon StockSEC:0001415889-24-005572:0
5,577 shares@ US$24.672.0% of flowCommon StockSEC:0001415889-24-005572:1
9,528 sharesCommon StockSEC:0001209191-24-001269:0
3,732 shares@ US$29.961.6% of flowCommon StockSEC:0001209191-24-001269:1
103,999 sharesCommon StockSEC:0001209191-23-052389:0
100,000 shares@ US$20.7729.5% of flowCommon StockSEC:0001209191-23-042641:0
100,000 shares@ US$30.043542.7% of flowCommon StockSEC:0001209191-23-042641:1
16,498 shares@ US$25.006.0% of flowCommon StockSEC:0001209191-23-042246:0
7,806 shares@ US$21.182.4% of flowCommon StockSEC:0001209191-23-026742:1
15,625 shares0Common StockSEC:0001209191-23-026742:0
17,333 sharesCommon StockSEC:0001209191-23-023862:0
10,945 sharesCommon StockSEC:0001209191-23-013472:0
9,528 sharesCommon StockSEC:0001209191-23-002900:0
3,904 shares@ US$17.13031.0% of flowCommon StockSEC:0001209191-23-002900:1
74,739 shares0Common StockSEC:0001628280-23-000421:0
38,580 shares0Common StockSEC:0001209191-22-062184:0
25 of 34 declarations
About Davis Stephen
DAVIS STEPHEN is President-CEO and Director. He has 34 filings in total, and across the recent filings tracked, sales total 4414283 EUR over the period from 2021-10-19 to 2024-08-20, with the transaction nature listed as Option exercise. He is associated with Acadia Pharmaceuticals INC, Bellicum Pharmaceuticals, INC, HERON THERAPEUTICS, INC. /DE/, and Heron Therapeutics, INC.
